ORGN 182 |
| There are many criteria that influence the scale-up efforts of leads at the late discovery stage. While these efforts have a lot in common with typical chemical development, there are some differences. Descriptive case studies will be presented to illustrate these points and show the impact of synthetic chemistry in the transit of discovery leads into full development. |
|
The Role of Organic Synthesis in Early Clinical Drug Development
8:30 AM-12:00 PM, Monday, 27 March 2006 Georgia World Congress Center -- C303/304/305, Oral
Division of Organic Chemistry |